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Purpose of this review: To determine whether type 2 diabetics treated with a low 
carbohydrate diet of at least four weeks duration have better intermediate 
outcomes, including glycemic control, hemoglobin Ale (HbgAlc), weight 
reduction, insulin sensitivity, triglycerides (TG), and lipid levels compared to type 
2 diabetics on a heart healthy or normal diet? 
Background/Introduction 
type 2 Diabetes 
Type 2 diabetes is a chronic disease that affects a growing number of 
Americans. Nearly 18.2 million Americans suffer from the disease today. 15 As 
the average age of the United States population has increased, so has the 
F 
incidence of obesity, hypertension, glucose intolerance, dyslipidemia, and type 2 ~ [--
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diabetes. In fact, the prevalence of type 2 diabetes has slowly risen over the past 
three decades, roughly paralleling the increase in the proportion of people, 
including children and young people, who are either overweight or obese5 The 
prevalence of type 2 diabetes in adults ages 40-74 increased from 8.9% during 
1976-80 to 12.3% during 1988-19944 Furthermore, type 2 diabetes is being 
diagnosed more frequently among younger and younger cohorts. 
Type 2 diabetes is a leading cause of morbidity and mortality in the United 
States, and is associated with both microvascular and macro vascular 
complications7 Debilitating microvascular complications include blindness and 
kidney failure 8 
Macrovascular complications, which comprise the majority of the 
morbidity and mortality associated with diabetes, 17 include heart disease, stroke, 
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and amputation. 17 Diabetics have a 2- to 4-fold higher risk of both coronary artery 
disease and stroke than non-diabetics. In 2003, the number of deaths directly 
attributable to diabetes was 47.7 per 10,000 individuals. 15 
In addition, diabetes is a disease of economic significance to the U.S. 
health care system. The U.S. spent over 98 billion dollars on medical care and 
lost productivity for type 2 diabetics in the 1997 fiscal year. 18 
Current evidence suggests that tight glycemic control is the best way to 
prevent many of the microvascular complications of type 2 diabetes. Several 
studies have provided substantial evidence to support tight glycemic control. For 
example, the Diabetes Control and Complications Trial (DCCT) and the United 
Kingdom Prospective Diabetes Study (UKPDS) both showed that tight glycemic 
control plays an important role in preventing the microvascular complications of 
diabetes, including retinopathy, neuropathy, and nephropathy. 19•20 
The UKPDS enrolled 3,867 newly diagnosed type 2 diabetics. The 
patients were randomized either to conventional diet control, sulphonylurea, or 
insulin therapy. Over ten years, hemoglobin A1c was 7.0% in the intensive 
therapy groups (i.e. sulphonylurea, insulin) compared to 7.9% in the conventional 
diet group. The result was a highly significant 25% reduction in the number of 
microvascular endpoints. There was no significant difference between insulin 
therapy and treatment with a sulphonylurea. None of the individual drugs had an 
adverse effect on cardiovascular outcomes, but all intensive treatment increased 
the risk of hypoglycemia. Although the UKPDS data suggested a trend toward 
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reduction in macrovascular outcomes, including amputation and myocardial 
infarction, convincing data in this area are lacking20 
Thus, intensive blood-glucose control in patients with type 2 diabetes 
substantially decreases the risk of microvascular complications but not 
macrovascular disease. Tight glycemic control may best be achieved through a 
combination of pharmacotherapy and lifestyle modifications.21 
Diet Therapy for Diabetes 
Dietary changes are one important lifestyle modification that play an 
important role in managing diabetes. In both the UKPDS and DCCT, dietary 
interventions played a key role in glycemic control.21 •22 Several additional studies 
have documented the effectiveness of dietary interventions in type 2 diabetics. 
One study showed a 2.0% absolute decrease in HbA1, in patients with newly 
diagnosed type 2 diabetes.23 Another study demonstrated a 1.0% absolute 
decrease in HbA1, in patients with an average 4-year duration oftype 2 diabetes24 
In addition to tight glycemic control, other risk factors for cardiovascular 
disease, such as hyperlipidemia and hypertension, are treated concurrently to 
further lower risk. In fact, the UKPDS studies failed to demonstrate that tight 
glycemic control leads to a decrease in macro vascular outcomes; the possibility 
exists that other risk factors (e.g. hyperlipidemia, hypertension) for cardiovascular 
disease may be more important. Thus, it is imperative that dietary 
recommendations for diabetics address other risk factors for cardiovascular 
disease in addition to glycemia. 
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Rationale for this study 
In the middle of a rapidly growing obesity epidemic, patients are 
constantly bombarded with fad diets and promises of amazing weight loss and 
health benefits. Low-carbohydrate diets have recently resurfaced as a means of 
rapid weight loss. Especially popular is the low carbohydrate diet promoted by 
Robert Atkins, MD, requiring individuals to consume <20grams (g) of 
carbohydrate a day during the initial stage of the diet. Because, by definition, 
these diets are low in carbohydrates, many have proposed that they would be 
especially beneficial for type 2 diabetics trying to stabilize their blood glucose 
levels 48.49•50 However, the long-term safety and efficacy ofthese diets remain 
largely unknown. Both the American Heart Association and the American 
Diabetes Association have cautioned against the use of these diets, pointing out 
that excess consumption of proteins and fats may promote hyperlipidemia, 
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Unfortunately, little is known about the long-term effects of a low-
carbohydrate diet on health. This study seeks to examine the current evidence for 
recommending a diet low in carbohydrates for type 2 diabetics. What impact does 
a low carbohydrate diet have on intermediate outcomes of health, including 
glycemic control, HgbAl c, weight reduction, insulin sensitivity, triglycerides 
(TGs), and lipid levels? Given the rising public interest in low carbohydrate diets, 
it is important that we know how newly proposed diets will affect type 2 diabetic 
. 103-104 patients. 
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Methods 
Selection Criteria 
Randomized controlled trials in the English language of patients with a 
clinical diagnosis of type 2 diabetes were eligible if one of the following 
interventions were included: low-carbohydrate, ketogenic, high protein, or high 
fat diets. All interventions had to have a maximum carbohydrate content of 45% 
of total energy, a level that was arbitrarily selected to include most "low 
carbohydrate" diets in the scientific literature. Additionally, one of the following 
outcomes had to be measured in the study: glycemia control, glycated hemoglobin, 
insulin sensitivity, weight change, lipids, or triglycerides. 
Studies were excluded if: 
• Participants were not type 2 diabetics, unless stratified randomization and 
analysis was done separating the type 2 diabetic group from the non-type 2 
diabetics. 
• Participants were pregnant 
• At least one outcome of interest was not incorporated . 
• Diets were not sustained for at least 4 days duration 
• Multiple diets were included in the same study 
Search Strategy and Data Sources 
Searches were performed on PUBMED for studies that were published 
between January 1, 1966, and March 16,2004 and met the eligibility 
requirements. Studies indexed with the keywords such as diet, diabetes, and low 
carbohydrate were sought (see Table 1 ). I also reviewed bibliographies of 
retrieved articles to obtain additional citations. 
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Abstraction Methods 
I reviewed 707 titles and abstracts identified by the combined MEDLINE 
search (see Tablel). I extracted study design and participant data to identify those 
studies that met inclusion criteria. I excluded duplicate studies of the same 
participant group. I examined studies that included multiple diets or participant 
groups for separate analysis ofthe type 2 diabetics. I excluded the studies without 
separate analysis and study arms with diets not meeting inclusion criteria. 
Data Abstraction 
The author extracted three main types of data: I) The dietary intervention, 
including percentage composition of carbohydrate, fat, and protein; 2) daily 
caloric content; and, 3) diet duration. Study data included total number of 
subjects, mean ages, and sex. The main outcome variables included weight 
change, glycemic control, glycated hemoglobin, insulin levels, and measures of 
serum lipid levels (low-density lipoprotein {LDL} cholesterol, high-density 
lipoprotein {HDL} cholesterol, and serum triglycerides. 
Internal Validity Check 
To assign grades to any recommendation, determine the strength of 
conclusions, or guide recommendations for future research, it is necessary to 
perform a quality assessment. The author performed a quality assessment starting 
at the point of study selection. 
I contructed a modified version of Verhage's delphi list, a criteria list for 
the quality assessment of randomized clinical trials for conducting systematic 
reviews25 The first row of Table 2 delineates the aspects of this tooL The 
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included components capture generic methodological issues not just specific to 
the subject area being reviewed. Specifically, the assessment components 
determined if the studies: 
• evaluated the similarity of baseline characteristics ofthe groups 
• used effective means of randomization 
• employed allocation concealment 
• provided evidence of masking patients 
• provided evidence of masking care providers 
• provided evidence of masking outcome assessors 
• provided point estimates of outcome variables with a measure of variability 
• looked for protection against bias 
• employed intention to treat analysis 
I assigned an overall quality grade to each study; either poor, fair, or good. 
Good quality studies scored an "adequate" on at least four of the nine components, 
and included an adequate method of randomization and analyzized data on an 
intent-to-treat basis. Adequate approaches to randomization included central 
randomization, computer-generated random numbers or random number tables. 
Inadequate approaches included use of alternation, case record numbers, birth 
dates, or week days. A grade of unknown was reported for studies that simply 
included the word "randomized" without further detail. 
I gave an overall quality grade of fair to those studies that received an 
adequate score on less than four components, or received an "unknown" on either 
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the approach to randomization or intent-to-treat analysis. A grade of poor was 
reserved for studies that had major design flaws, including an inadequate 
approach to randomization or data anlysis not performed on an intent-to-treat 
basis. 
TABLEl Literature Search Strategy 
Description Articles 
MELINE key word searches 
Search 1, diet* 282,781 
Search 2, diabetic 103,706 
Search 3, NIDDM 30,829 
Search 4, diabetes 212,085 
Search 5, low carbohydrate* 645 
Search 6, high fat* 6,531 
Search 7, high protein* 3,807 
Search 8, ketogenic 853 
Search 9, isocaloric 2,951 
Search 10, hypocaloric 753 
Search 11, protein sparing 2,241 
Search 12, carbohydrate restricted 6,908 
Combine searches: 1 AND (2 OR 3 OR 4) AND (5 OR 6 707 
OR 7 OR 8 OR 9 OR 10 OR 11 OR 12) LIMIT to 
participant type: human 
Exclusion Criteria 
Not an adult study 287 
Articles not in English 73 
Review articles 154 
No dietary intervention 85 
Study did not examine type 2 diabetes 76 
Diet duration less than 4 days 47 
No outcome of interest 95 
Non-human trial 1 
Inpatient study 5 
Pregnancy study 10 
Total articles excluded from those found in MEDLINE 635 
search 
Articles included from manual search of bibliographies 2 
Articles not available free of charge from UNC libraries 52 
Total articles included in analysis 12 
Combined duplicate reports on the same study 0 
participants 
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Table 3. Study Characteristics 
Study N Participants Duration Sex No. Of Total Carbs, Fat, Protein, 
Age, SD of Diet % Study Kilocalorie g g g 
Male Arms s per Day 
Ash et al. 51 Men up to 70 12 wks 100 3 1400-1700 
years of age 
54+/- 9 
Facchini et al. 100 59 (10) 4 yrs 53 2 .8 g/kg I 
control 
91 60 (12) 48 
Gutierrez et al. 28 67 (6.2) 7.9 wks 29 2 
crossover 
design 67 (6.2) 12 wks 
Hollander et al. 159 54.7 (9.7) 52 wks 53 2 500 
162 55.4 (8.8) 52 wks 49 500 
Heilbrmm et al. 55 56.0 (9.4) 4 wks 46 2 1500 
Crossover 57.5 (9.6) 4 wks 57 1500 
design 56.0 (9.4) 8 wks 46 1500 213 31 83 
57.5 (9.6) 8 wks 57 1500 218 30 78 
Luscombe et al. 11 64.2 +/-3.3 8 wks 55 2 1600 60 
15 62.2 +/-2.2 8 wks 33 1600 110 
SEM 
Madigan et al. 56.0 (2.5) 
56.0 (2.5) 
Markovic et al. 9 47.6 +/- 4.8 2 wks 44 2 1100 132 8 122 
Ozata et al. 20 41.6 (8) 3 mon 100 2 1200-1400 
Nuttall et al. 12 5 wks 83 1 299 
Crossover 5 wks 83 223 
design 
Parker et a!. 54 63.4 +/- 1.7 8 wks 35 2 1587 36 
Crossover 64.2 +/- 3.8 8 wks 36 1543 
design 63.4 +/- 1.7 4 wks 35 2029 
64.2 +1- 3.8 4 wks 36 1785 
Samaha et al. 52 54 (9) 6mon 80 2 1630 <30 
54 (10) 6mon 85 1576 <30%tot 
12 
Table 4. Outcomes oflnterest 
Study Mean Diet C:F:P Duration Mean Age Insulin Weight Glycemia HgbAlc LDL TG fiDL 
Reduction (%energy) of diet Sensitivity as loss in kg Fasting reduction change change change 
in intake 0/o change in blood Mmol/1 
insulin levels change 
(mg/dl) 
Ash et al. 564 +/- 665 50:30:20 12 wks Men up to 6.4 +/- 4.6 1.0 +/- TG- 0.3 
kcal/day 70 years of SD 1.4% +/- 0/6 
age nm1o111 
54+/- 9 
Facchini et al. 35:30:30:5 4 years 59 (10) 2.0 N.S. +.007 +. 23 
vs 65:25:10 4 years 60 (12) 1.0 -.012 -.05 
Gutierrez et al. 25:45:30 7.9 wks 67 (6.2) 1.4(15) -66 1.8 
Vs. 
55:20:25 12 wks 67 (6.2) + 1.0 -74 1.0 
Hollander et al. Orlistat 50:30:20 52 wks 54.7 (9.7) -4.3 +/- 6.3% 4.3 +1-.5 -10+/-2 .88 +. 22 +/. .21+/-.08 +. 08+/-
50:30:20 52 wks 55.4 (8.8) -5.2 +/- 4.4% 6.2 +/-.5 -15 +/- 2 .83 06 -.01+/-.07 .01 
SEM 95CI SEM -.13+/-.05 +. 06+1-
.OJ 
Heilbrmm et al. GI Index 50:30:20 4 wks 56.0 (9.4) 3.3 4 .09 -.07 -.45 +.01 
50:30:20 4 wks 57.5 (9.6) 4.0 9 .31 -.12 -.13 +0 
60:15:20 8 wks 56.0 (9.4) 4.4 6 .61 -.54 -.12 +.OJ 
60:15:20 8 wks 57.5 (9.6) 4.8 4 .29 -.34 -.18 +. 02 
Luscombe et al. 55:30:15 8 wks 64.2 +/-3.3 4.3 +/-.7 
40:30:30 8 wks 62.2 +/-2.2 4.9 +/-.4 
SEM 
Madigan et al. Not 2 wks 56.0 (2.5) 
available 2 wks 56.0 (2.5) 
Markovic et al. 1200 38:29:33 4 wks 47.6 +/- 4.8 6.2 +/-.4 -.55 -.21 
kcallday 
Ozata et al. 3 mon 41.6 (8) 1.97 -37 
Nuttall et al. 55:30:15 5 wks -.3 
Gannon et al. 40:30:30 5 wks -.8 
Parker et al. 40:30:30 8 wks 63.4 +/- 1.7 -26% 4.5 -18 -.54 -.30 -.48 -.01 
60:25:15 8 wks 64.2 +/- 3.8 -15% 4.5 -12 -.51 -.12 -.41 -.04 
+442 kcal 40:30:30 4 wks 63.4 +/- 1.7 -11% 1.1 6 +. 11 +. 12 0 
+242 kcal 60:25:15 4 wks 64.2 +/- 3.8 +6% .3 5 +.20 +. 18 +.05 
Samaha et al. 460 37:41:22 6mon 54 (9) -20 (75) -26(31) -.6 (1.2) 
271 51:33:16 6mon 54 (10) 0 (56) -5 (31) 0 (1.0) 
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Ill. Results 
Articles Identified 
My MEDLINE search identified a total of707 potentially eligible articles. Reference searching 
identified two additional stndies. After abstract review, a total of 64 articles met the inclusion criteria. 
Twelve of these articles were available free of charge through UNC libraries and were included in the 
analysis (Table 1). 
Quality of the Studies 
The modfied version oft he Delphi list, a criteria list for the quality assessment of randomized 
clinical trials for conducting systematic reviews was applied to the identified studies. Table 2 
summarizes the results of this assessment. Overall, five of the 12 studies received a grade of good. 
Three of 12 received a grade of fair, and the remaining four had a major methodological flaw and 
received a grade of poor. 
All 12 of the identified studies clearly specified the eligibility criteria. All 12 reported similar 
baseline characteristics of the groups initially and presented point estimates and a measure of variability 
for the outcomes of interest. Only four of the studies clearly stated the method of randomization; the 
other eight simply employed the word "randomized." The treatment allocation was determined to be 
blinded from the physicians in only four ofthe studies; the other eight did not provide enough 
information to deduce this. None of the studies stated whether the outcome assessors were blinded. 
Four of the 12 did not employ intent-to-treat analysis, and received the grade of "poor" overall 
quality. The four "poor" quality studies are excluded from subsequent analysis and discussion in this 
rev1ew. 
Study Characteristics 
The eight "fair" or "good" quality studies included a total of 18 different dietary interventions 
(Table 3). All ofthe studies were randomized controlled trials in which the patients were randomized to 
one of two or more dietary interventions. Additionally, the studies varied in design, as three of the 
studies were crossover designs. In these three studies, the patients first were randomized to receive one 
diet, then after a specified period of time received a second diet. The number of participants in the 
studies ranged from 12 to 391. 
Some of the diets included a washout phase at the beginning of the study during which patients 
received s standard diet intended to mimic their normal diets in caloric and carbohydrate content. In 
these studies, the weight at end of washout period was recorded as the patients' baseline weights. 
Diet Characteristics 
The dietary interventions were also highly heterogeneous. The duration of the diets ranged from 
4 weeks to 52 weeks (Table 4). Furthermore, the average number of kilocalories per day ranged from 
500 kcal/day to 2029 kcal/day (Table 3). The percentage of carbohydrate in the diets ranged from 25% 
to 65% of total energy, and only five of the eight "fair" or "good" quality diets included the total daily 
kilocalorie intake. Five of the diets reported dietary composition ranges in grams of carbohydrates, 
proteins, and fat. 
Most of the dietary interventions prescribed a diet and had the patients keep a daily log. This 
self-reported log was used to calculate the actual dietary interventions' total calories and amount of 
carbohydrate in diet. A few studies actually provided prepackaged meals to ensure that participants 
received precisely the prescribed dietary intervention. The Madigan dietary intervention included a 
significant amount of linoleic acid-rich sunflower oil in the diet. 
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Patient Characteristics 
The average age of participants in the different studies ranged from 41.6 to 67 years (Table 3). 
Two of the studies examined only men. The Facchini study recruited a cohort of more advanced type 2 
diabetic patients referred to nephrology clinics for various degrees of renal failure and otherwise 
unexplained proteinuria. The Gutierrez study included an arm of patients treated with second-generation 
sulfonylurea agents. The Parker study excluded patients with any degree of proteinuria. 
Several of the studies were limited to patients with varying degrees of obesity. For example, the 
Ash cohort included men with a body mass index (BMI) between 25 and 40. The Hollander study 
included patients with a BMI ranging between 28 and 40, and the Samaha study cohort included only 
severely obese patients with an average BMI of 43. 
Outcome Measures for the Low-Carbohydrate Interventions 
Three of the studies reported insulin sensitivity as a percent change in serum insulin levels. The 
Parker study showed a greater decrease in serum insulin levels in the two arms that had lower 
carbohydrate contents (60% versus 40%). The Samaha study, which included an arm with 37% 
carbohydrate content, showed a decrease in serum insulin level compared to the 51% carbohydrate arm, 
which showed no change. The Hollander study included two 50% carbohydrate arms which both 
showed a comparable decrease in serum insulin levels 
Change in weight was reported in all but two of the studies. Most of the studies showed weight 
loss of varying degrees. The weight in most of the studies was usually greater in the low carbohydrate 
groups. 
Fasting blood glucose levels also dropped in most ofthe studies. In the Guitierrez, Parker, and 
Samaha studies, the decrease in fasting blood glucose was greater in the lower carbohydrate containing 
diets. 
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All ofthe diets demonstrated a reduction in glycated hemoglobin Ale levels, except for the 
Facchini study, which failed to demonstrate any significant increase or decrease. The Gutierrez, Nuttall, 
Samaha, and Parker studies showed a greater reduction in the low carbohydrate arm 
The lipid findings were equivocal. The Facchini study found a greater drop in LDL in the high 
carbohydrate containing arms, but Parker found the converse. The Parker study demonstrated an 
increase in LDL levels in two of the arms, which was greater in the higher carbohydrate-containing arm. 
Similar equivocal results were found for triglyceride levels 
A change in HDL levels was reported in three of the dietary interventions. Facchini show an 
increase in the 35% carbohydrate-containing mm, but a decrease in levels in the 65% carbohydrate-
containing arm. Parker showed a small increase in one 60% carbohydrate-containing arm, compared to 
no change in the 40% containing arm. The other two Parker arms both showed decreases in HDL levels, 
with a greater decrease in the 60% containing arm. 
IV. Discussion 
Based on the current studies, the evidence suggests that adherence to a low carbohydrate diet of 
at least four days duration may lead to weight loss and lower semm insulin levels. However, the data 
are equivocal for the other intermediate outcomes, including serum glucose levels, hemoglobin A I c, and 
lipid levels. 
There is variability among studies with regard to internal validity. Many studies may be biased 
due to unsuitable comparison interventions, lack of blind outcome assessment, inadequate follow-up 
times, and inability to define or assess relevant outcomes, or unreliable measurement techniques. The 
variation in the quality of selected primary studies has implications for data synthesis, interpretation of 
results, and generation of inferences in this review. 
18 
L 
For example, the Gutierrez study's crossover design makes interpretation of results difficult. 
Patients are first on low carbohydrate/high fat diet, and then cross over to a higher carbohydrate L 
containing diet. Measuring the change in outcome variables using data from the beginning of the low 
carbohydrate diet period may not be valid, as patients were not eating their normal diet at that time. 
This problem was not unique to the Gutierrez study, as some of the other studies had run-in periods 
while others did not. Prescribing a particular dietary intervention to a patient at the clinic cannot be 
based upon changes from a run-in period diet, unless that diet reflects what the patients normally 
consume. In this way, nm-in periods and crossover designs may hurt the external validity ofthe 
studies' results. 
Many of the studies were small and had limited power to detect significant differences in 
between intervention groups. In fact, few of the differences in outcomes outside of weight loss were 
significant. Over half the studies had less than 60 total participants. Difficulties and complexities in 
monitoring the dietary intake of individuals are likely to be one reason the studies have been small to 
date. A meta-analysis would be useful but extremely difficult to conduct due to the heterogeneity ofthe 
individual interventions. 
The Ash study and Samaha study both suffered drop-outs. The Ash study lost only 5 of 51 
patients to follow-up. The subjects lost were similar between groups and were comparable to the 
original population with regards to baseline characteristics. The Samaha study had a much higher drop-
out rate, losing 53 of 132 patients to follow-up, and used last observation carried forward for those who 
dropped out. Although the study showed an increase in insulin sensitivity and improved glycemic 
control markers, it is possible the results were influenced by the high drop-out rate. Thirty-two of the 53 
drop-outs came from the higher carbohydrate group. It is possible that individuals compliant with the 
higher carbohydrate (and lower fat-containing) diet were more likely to drop-out from the study than 
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individuals who were less compliant. This could skew results if those compliant individuals would have 
lost weight and reaped some of the clinical benefits associated with weight loss. 
Additionally, many of the studies provided prepackaged meals to participants, which means 
larger trials would cost significantly more. Furthermore, supplying participants with prepackaged meals 
is a threat to the study's external validity. A physician or dietician in the field prescribing a low 
carbohydrate diet to a patient will likely not be supplying the prepackaged meals to ensure compliance, 
and application to long-term therapy is limited by the patients' willingness to pay for prescribed meals. 
Regardless, the use of prepackaged meals for a short period of time was thought to transfer knowledge 
of appropriate portion sizes and food types to patients. However, the Ash study included a subsequent 
follow-up 15 months after the free supply of prepackaged meals to patients was discontinued, and the 
weight loss was not sustained in the long term. This result is consistent with previous studies providing 
prepackaged meals51 
Another factor that contributes to the heterogeneity and makes comparisons more difficult 
among studies is the fact that some of the studies use the simple prescription of a particular diet as the 
intervention, while others relied on a dietary recall or diary to evaluate whether the patients actually 
followed the prescribed diet. Still others provide prepackaged meals to avoid recall bias and ensure the 
accuracy of data. It is likely that patient adherence varies between the different dietary intervention 
types. The studies relying solely on the prescription of a diet may have the most external validity, as 
that is what physicians and dieticians will be doing in the field. 
However, it is important that we not draw conclusions about the efficacy of a low carbohydrate 
diet from studies relying on dietary recall to ensure compliance. Sources of error in short-term dietary 
recalls and records have been well documented40' 41 Most the studies included in this review relied on 
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subject recall or records, and are thus subject to several biases.40 These errors may be respondent or 
recorder based. 
Respondent based errors stem from the fact that accurate recall depends on several factors. The 
respondents must be motivated, aware of their food intake, and have adequate memory and 
communication skills. One study found that respondent knowledge of the study's purpose affected the 
measurement of food intake41 The same study also showed that respondent fatigue, related to length of 
survey, influenced results. Another study showed that continual contact with physicians increased the 
accuracy of the reports.42 A third study found that men frequently did not list all the food they 
consumed because they were embarrassed to admit how much they had consumed43 All of these 
respondent based errors affect the external validity of the studies. 
Many of the studies in this review relied on dietary logs with the subject using household 
measures to estimate the quantity eaten (i.e. a "fistful" of beans, or even more inaccurate, a "large or 
small" portion). These household measures are then converted to grams by the investigators. However, 
the type of conversion inevitably leads to a loss of precision. A study by Guthrie et al. found that 
amounts of butter, salad dressing, cereal, and salads were overestimated by more than 51% over two-
thirds of the time, and the intake of salad dressings, butter, sugar, and salad were underestimated by at 
least 51% a quarter of the time44 To make matters worse, some specific types of foods tend to be 
erroneously recalled while others tend to be erroneously omitted. A 1985 study found that cooked 
vegetables tend to be omitted more frequently than other types of food, while sugar containing foods 
4' tend to be erroneously recalled more frequently.·' 
A study by Prentice et al. compared the energy expenditures of a group of lean and a group of 
obese women with their self-reported dietary records.46 They used isotopically measured total energy 
expenditures and found that the obese group had a 28 percent higher daily energy expenditure than the 
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lean group, but tended to underestimate tbeir intake by 837 kcal/day. The lean group accurately self-
estimated their intake. This bias has significant implications for this review, as many of the included 
studies were of obese patients. If obese patients tend to underreport the amount of carbohydrate they 
consume and low-carbohydrate diets contribute to a feeling of satiety, then it is possible that control 
groups eating higher amounts of carbohydrate are underreporting their consumption in some ofthe 
studies. 
Frank et al. found that the amount of training an interviewer receives can effect the amount of 
food recalled, and thus has implications for comparing the results of more than one study47 Well-trained 
interviewers using a detailed protocol substantially improved the reliability and reproducibility of 
dietary recalls. Furthermore, the behavior ofthe interviewer may affect results, especially if more than 
one interviewer is used in a study.40 The manner of asking questions can affect answers, and the 
resulting information may vary depending on whether the probing is general or detailed. This facet 
undoubtedly contributes to the heterogeneity of the studies. Unfortunately, very few of the studies state 
what kind of training the interviewers received in detail, or how many different interviewers were used. 
Studies of prescribed diets, which measure effectiveness, may provide more externally valid 
results, as this is what health care professionals will be doing in the field. Furthermore, dietary 
prescriptions that require patients to keep a log of their meals may not be comparable to prescription 
alone, as there may be benefit in requiring subjects to write down their intake daily. All of these factors 
make comparisons and conclusions a very messy business. 
Most of the studies are consistent with the hypothesis that weight loss produces improvements in 
glycemic control. In general, the most hypocaloric diets seem to have better results. However, the 
included diets in this review were not isocaloric. Additionally, the low-carbohydrate diets vary 
significantly with calorie intake from carbohydrates. This heterogeneity makes it difficult to compare 
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diets. Since only one of the diets reported the main reduction in caloric intake from baseline (Ash et al.), 
it is difficult to ascertain whether the beneficial effects in any of the outcome variables are due to the 
implementation of a low carbohydrate diet or a low caloric diet which leads to weight loss in general. 
Conversely, some authors hypothesize that dietary interventions that are low in carbohydrate 
lead to weight loss because more fat or protein helps provide a feeling of satiety. Patients on low 
carbohydrate diets may consume less food and less overall total calories compared to a higher 
carbohydrate diet. Less overall caloric intake then leads to weight loss, and we see the usual benefits 
associated with weight loss. If this is true, then setting up randomized controlled trials with isocaloric 
diets would negate the satiety effects of the diet and intervention group would be similar to the control 
group. 
Source of error 
If I were to publish this systematic review, a huge potential bias exists. After abstract review, a 
total of 68 articles were identified that may have met the inclusion criteria. Fifty-two ofthese were not 
available free of charge. Of the 16 that were acquired, only 12 of these (75%) met the inclusion criteria 
after careful examination. Thus, of the remaining 52 unacquired articles, if 75% of these truly met the 
inclusion criteria, 36 articles were omitted. It is noteworthy that the UNC health science library 
provides free access to the more reputable journals, and it is likely the included studies are of higher 
quality than the omitted studies. 
Conclusion and Recommendation 
In conclusion, the data regarding the effectiveness of low carbohydrate diets for type 2 diabetics 
-
are limited. The studies have been small, of varying quality, and very heterogeneous with respect to 
dietary interventions and methodology. Weight loss, in general, is probably beneficial for type 2 
diabetics. However, there is insufficient evidence to recommend for or against the specific use oflow 
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carbohydrate dietary interventions in type 2 diabetics. Larger studies of better quality must be 
conducted and methodology must be standardized to allow pooling of data. It is possible that the dietary 
interventions must stay below a maximum threshold of dietary carbohydrate for benefits to be elicited. 
Furthermore, new variables such as the glycemic index of the carbohydrates included in the diet or what 
food replaces the carbohydrates may be equally important. Future research must address these questions. 
Based on the current evidence, it is this author's opinion that type 2 diabetics should be 
counseled that weight loss in general will be beneficial, providing them with numerous well documented 
health benefits. If individuals wish to pursue weight loss through a low carbohydrate diet, physcians 
should advise them that conslusive evidence of their benefits independent of weight loss is lacking, and 
that the long term effects of low carbohydrate diets are largely unknown. 
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